Cognition Therapeutics Inc (CGTX) Key Ratios
$1.03
As on 04-Sep-2026 13:37EDT
Market cap
$97 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
3.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -- | 61.08 | 12.77 | -217.94 |
| Net Profit | 13.96 | 41.61 | 49.16 | 8.04 | -207.04 |
| EPS | 15.32 | 58.96 | 70.28 | 20.89 | 3.07 |
| Book Value | -- | -- | -4.54 | -34.76 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -2,162.86 | -- | -- | -- |
| Return on equity
| -108.49 | -37.05 | -49.86 | -88.60 | -157.19 |
| Return on Capital
| -104.26 | 53.23 | -- | -86.23 | -150.06 |
| Return on Assets
| -74.63 | -51.58 | -43.95 | -59.75 | -103.89 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.02 | 0.04 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
--
|
-86.23
|
-150.06
|
-76.48
|
1.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-49.86
Lower than Peers by 9.46
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
-49.86
|
-88.60
|
-157.19
|
-79.69
|
1.65
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-43.95
Lower than Peers by 12.97
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
-43.95
|
-59.75
|
-103.89
|
-60.26
|
1.38
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
--
|
--
|
--
|
--
|
-2,162.86
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
EBIT Growth
61.08
Higher than Peers by 61.88
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
61.08
|
30.85
|
-31.77
|
-20.55
|
-97.44
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
49.16
Higher than Peers by 56.46
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
49.16
|
30.86
|
-31.73
|
-3,506.61
|
106.46
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
70.28
Higher than Peers by 55.63
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
70.28
|
0.64
|
0.13
|
-33.09
|
1.05
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
230.19
Higher than Peers by 240.37
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
230.19
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
--
|
0.02
|
0.04
|
0.05
|
0.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
0.00
|
0.01
|
0.03
|
0.03
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
7.03
Higher than Peers by 1.22
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
7.03
|
3.45
|
2.65
|
3.37
|
6.11
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
7.03
Higher than Peers by 1.33
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
7.03
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-1,289.38
Lower than Peers by 1,287.30
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
-1,289.38
|
-1,805.69
|
-1,357.84
|
-954.11
|
-763.18
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
--
|
--
|
--
|
--
|
3,099.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
--
|
2,485.46
|
3,898.98
|
5,008.42
|
5,738.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
--
|
-5.11
|
-0.96
|
-2.21
|
80.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
3.08
Lower than Peers by 2.10
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
3.08
|
3.50
|
1.74
|
2.33
|
1.51
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.44
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
-0.44
|
-3.61
|
-0.25
|
-1.11
|
-0.98
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
97
Lower than Peers by 49
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc (CGTX)
|
97
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|